Izotropic (TSE:IZO) has released an update.
Izotropic Corporation has successfully completed the initial segment of their non-brokered private placement financing, raising $180,000 through the issuance of 1.8 million units at $0.10 each, with each unit comprising a share and a warrant. The funds raised are earmarked for essential regulatory compliance costs, operational maintenance, and strategic initiatives including FDA processes and patent-related expenses. This financing move is subject to customary regulatory approvals and includes a four-month holding period for the securities issued.
For further insights into TSE:IZO stock, check out TipRanks’ Stock Analysis page.
